Format

Send to

Choose Destination
N Engl J Med. 2017 Sep 21;377(12):1114-1117. doi: 10.1056/NEJMp1705800.

The Fate of FDA Postapproval Studies.

Author information

1
From the Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, NH (S.W., L.M.S.); AtlantiCare Regional Medical Center, Pomona, NJ (B.W.) ; the Institute for Safe Medication Practices, Alexandria, VA (T.J.M.); and the Department of Epidemiology and Biostatistics, George Washington University Milken Institute School of Public Health, Washington, DC (T.J.M.).

Comment in

PMID:
28930510
DOI:
10.1056/NEJMp1705800
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center